Better Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019
Market Capitalization	0	26	110	76	236
Market Cap Growth	-	-76.17%	45.22%	-67.98%	-
Enterprise Value	8	25	79	76	240
PE Ratio	-0.60	-0.66	-2.72	-11.83	-40.72
PS Ratio	-	-	-	9446.88	13110.95
PB Ratio	-1.42	-29.09	2.99	-11.18	-390.08
P/FCF Ratio	-0.51	-0.87	-3.44	-9.35	-26.36
P/OCF Ratio	-0.54	-0.90	-3.56	-13.09	-37.96
EV/Sales Ratio	-	-	-	9511.50	13346.68
EV/EBITDA Ratio	-0.76	-0.66	-2.57	-12.18	-42.14
EV/EBIT Ratio	-0.68	-0.62	-2.45	-12.03	-41.61
EV/FCF Ratio	-0.79	-0.84	-2.47	-9.42	-26.83
Debt / Equity Ratio	-1.44	-16.55	0.26	-0.09	-8.26
Debt / EBITDA Ratio	-0.50	-0.39	-0.31	-0.10	-0.88
Debt / FCF Ratio	-0.52	-0.49	-0.30	-0.08	-0.56
Quick Ratio	0.51	1.17	8.57	0.20	1.56
Current Ratio	0.57	1.37	9.56	0.76	2.03
Asset Turnover	0	0	0	0.00	0.00
Interest Coverage	10.31	-25.66	-165.19	-63.23	-524.82
Return on Equity (ROE)	317.73%	4422.69%	-109.84%	94.51%	957.85%
Return on Assets (ROA)	-294.47%	-173.30%	-79.15%	-100.00%	-118.73%
Return on Capital (ROIC)	-677.64%	-273.67%	-66.11%	103.35%	-131.35%
Earnings Yield	-7239.44%	-152.05%	-36.75%	-8.45%	-2.46%
FCF Yield	-6299.11%	-115.15%	-29.06%	-10.69%	-3.79%
Buyback Yield / Dilution	-62.47%	0.19%	-212.31%	67.98%	-
Total Shareholder Return	-62.47%	0.19%	-212.31%	67.98%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.